Department of Veterinary Pathobiology, The University of Missouri-Columbia, 1600 East Rollins Street, Columbia, MO 65211, USA.
Integr Biol (Camb). 2012 Oct;4(10):1215-22. doi: 10.1039/c2ib20118f.
Regucalcin plays a pivotal role in regulating intracellular calcium homeostasis and consequently has a profound effect on multiple intracellular signal transduction pathways. The regucalcin transgenic rat displays pronounced bone loss and hyperlipidemia. Consistent with these effects exogenous regucalcin has been shown to promote osteoclastogenesis in mouse bone marrow cultures and to suppress the differentiation and mineralization of MC3T3 osteoblast precursors. Regucalcin may induce hyperlipidemia in vivo by suppressing osteoblast differentiation and stimulating adipogenesis in bone marrow mesenchymal stem cells. The present study demonstrates that exogenous regucalcin suppresses differentiation to osteoblasts and stimulates adipogenesis in mouse bone marrow cell culture ex vivo. Moreover, exogenous regucalcin was found to enhance adipogenesis stimulated by insulin which is involved in the extracellular signal-related kinase pathway in 3T3-L1 adipocytes in vitro.
Regucalcin 在调节细胞内钙离子稳态方面发挥着关键作用,因此对多种细胞内信号转导途径有深远影响。Regucalcin 转基因大鼠表现出明显的骨丢失和高血脂。与这些作用一致,外源性 Regucalcin 已被证明可促进小鼠骨髓培养物中的破骨细胞生成,并抑制 MC3T3 成骨前体细胞的分化和矿化。Regucalcin 可能通过抑制成骨细胞分化和刺激骨髓间充质干细胞中的脂肪生成来诱导体内高血脂。本研究表明,外源性 Regucalcin 可抑制小鼠骨髓细胞培养物中的成骨细胞分化并刺激脂肪生成。此外,还发现外源性 Regucalcin 可增强胰岛素刺激的脂肪生成,胰岛素参与了体外 3T3-L1 脂肪细胞中的细胞外信号相关激酶途径。